Connection

George Gao to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications George Gao has written about Antibodies, Monoclonal.
George Gao
Connection Strength
0.365
Antibodies, Monoclonal
  1. Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab. Cell Rep. 2018 10 23; 25(4):909-920.e4.
    View in: PubMed
    Score: 0.191
  2. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat Microbiol. 2019 07; 4(7):1231-1241.
    View in: PubMed
    Score: 0.049
  3. Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab. Protein Cell. 2018 01; 9(1):135-139.
    View in: PubMed
    Score: 0.045
  4. An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun. 2017 02 06; 8:14369.
    View in: PubMed
    Score: 0.042
  5. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell. 2021 06 24; 184(13):3438-3451.e10.
    View in: PubMed
    Score: 0.014
  6. Testing Experimental Therapies in a Guinea Pig Model for Hemorrhagic Fever. Methods Mol Biol. 2018; 1604:269-278.
    View in: PubMed
    Score: 0.011
  7. Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design. PLoS Pathog. 2017 12; 13(12):e1006777.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.